Study title: Titolo protocollo: SAFETY AND EFFICACY OF ACETYL-L-CARNITINE SUPPLEMENTATION IN PEDIATRIC PATIENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: A PHASE II, DOSE RANGING TRIAL
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Nervous System Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: ACETYL-L-CARNITINE | |||||
| ATC code: N06BX12 | |||||
| Document link: ST 01 101 linelisting2011.xls | |||||
| Document date: 2011-09-15 | |||||
| Study number: ST 01-101 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |